We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$39.9B
AUM Growth
+$4.88B
(+14%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
7.63%
Holding
3,452
New
521
Increased
1,149
Reduced
1,091
Closed
479
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAN
2576
DELISTED
GAN Ltd
GAN
| $220K | ﹤0.01% |
134,154
-173,786
| -56% | -$248K |
|
2577
Neuronetics
STIM
$166M
| $218K | ﹤0.01% |
101,485
-52,549
| -34% | -$127K |
|
2578
Stoke Therapeutics
STOK
$2.11B
| $218K | ﹤0.01% |
20,500
+3,500
| +21% | +$37.2K |
|
2579
DHI Group
DHX
$173M
| $216K | ﹤0.01% |
56,518
-47,215
| -46% | -$175K |
|
2580
TeraWulf
WULF
$8.52B
| $215K | ﹤0.01% |
123,136
-74,172
| -38% | -$113K |
|
|
FINV
2581
FinVolution Group
FINV
$1.15B
| $215K | ﹤0.01% |
46,735
-115,800
| -71% | -$477K |
|
2582
EPR Properties
EPR
$4.77B
| $215K | ﹤0.01% |
+4,585
| New | +$193K |
|
|
AKU
2583
DELISTED
Akumin Inc
AKU
| $214K | ﹤0.01% |
1,187,002
-382,000
| -24% | -$175K |
|
2584
Matrix Service
MTRX
$335M
| $214K | ﹤0.01% |
36,271
-31,625
| -47% | -$173K |
|
2585
Oramed Pharmaceuticals
ORMP
$179M
| $213K | ﹤0.01% |
59,600
-446,655
| -88% | -$1.43M |
|
2586
UFP Technologies
UFPT
$2.43B
| $213K | ﹤0.01% |
1,100
-28,243
| -96% | -$4.37M |
|
2587
Cognyte Software
CGNT
$680M
| $213K | ﹤0.01% |
35,000
-3,500
| -9% | -$16.3K |
|
|
WOW
2588
DELISTED
WideOpenWest
WOW
| $213K | ﹤0.01% |
25,200
+10,716
| +74% | +$96.8K |
|
2589
Alaunos Therapeutics
TCRT
$4.86M
| $213K | ﹤0.01% |
2,778
-3,762
| -58% | -$304K |
|
2590
LXP Industrial Trust
LXP
$3.57B
| $211K | ﹤0.01% |
4,338
-24,586
| -85% | -$1.22M |
|
|
DZSI
2591
DELISTED
DZS Inc. Common Stock
DZSI
| $211K | ﹤0.01% |
+53,256
| New | +$312K |
|
2592
Caribou Biosciences
CRBU
$164M
| $211K | ﹤0.01% |
+49,626
| New | +$223K |
|
2593
V2X
VVX
$2.65B
| $208K | ﹤0.01% |
+4,200
| New | +$183K |
|
|
AOMR
2594
Angel Oak Mortgage REIT
AOMR
$209M
| $208K | ﹤0.01% |
+25,226
| New | +$195K |
|
|
CIR
2595
DELISTED
CIRCOR International, Inc
CIR
| $207K | ﹤0.01% |
3,674
-27,901
| -88% | -$978K |
|
2596
OmniAb
OABI
$447M
| $206K | ﹤0.01% |
40,900
+27,200
| +199% | +$110K |
|
2597
UroGen Pharma
URGN
$2.29B
| $205K | ﹤0.01% |
+19,815
| New | +$219K |
|
2598
Hancock Whitney
HWC
$6.24B
| $205K | ﹤0.01% |
5,342
-3,737
| -41% | -$139K |
|
|
AAT
2599
American Assets Trust
AAT
$1.4B
| $205K | ﹤0.01% |
10,652
-150,299
| -93% | -$2.82M |
|
2600
Tango Therapeutics
TNGX
$4.41B
| $204K | ﹤0.01% |
61,560
-11,696
| -16% | -$42.1K |
|
Similar funds
VAM
Two Sigma Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Two Sigma Investments held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Two Sigma Investments deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- Two Sigma Investments's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- Two Sigma Investments's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- Two Sigma Investments fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- Two Sigma Investments's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- Two Sigma Investments opened 521 new positions and closed 479 in Q2 2023.
- Two Sigma Investments's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.